家族性早发性卵巢功能不全队列的全外显子组测序在50%家系中检出广泛致病或可能致病变异
本研究为横断面研究,纳入36个家系的36例家族性早发性卵巢功能不全(POI)先证者及52名亲属,行核型分析、FMR1筛查、单核苷酸多态性微阵列分析和全外显子组测序(WES)。18/36例先证者(50%)检出致病或可能致病变异,其中12个家系为已知POI基因变异,6个家系为新候选基因变异,多数变异位于细胞分裂和减数分裂(n=11)或DNA修复(n=4)相关基因。
要点
- 家族性POI先证者中WES诊断率为50%(18/36)。
- 12个家系检出已知POI基因的致病或可能致病变异。
- 6个家系检出新的候选基因致病或可能致病变异。
核心结论
- 家族性POI的遗传病因诊断有助于遗传咨询、妊娠计划和卵巢或卵母细胞保存。
- 识别新基因可能基于受扰的分子通路推动未来生殖治疗的发展。
研究设计与样本
- 横断面研究,纳入36个家系的36例家族性POI先证者,52名亲属(25例POI患者和27名未患病者)。
- 所有受试者均行核型分析、FMR1筛查、单核苷酸多态性微阵列分析和全外显子组测序(WES)。
主要发现
- 18/36例先证者(50%)检出致病或可能致病变异作为可能的分子病因。
- 12个家系检出已知POI相关基因的致病或可能致病变异,6个家系检出新的候选基因的致病或可能致病变异。
- 多数变异位于细胞分裂和减数分裂相关基因(n=11)或DNA修复相关基因(n=4)。
临床怎么用
- 原文结论指出POI的遗传病因诊断可提供遗传咨询、妊娠计划和卵巢组织或卵母细胞保存,作者认为识别新基因可能推动未来生殖治疗发展。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To study the diagnostic yield, including variants in genes yet to be incriminated, of whole exome sequencing (WES) in familial cases of premature ovarian insufficiency (POI). DESIGN: Cross-sectional study. SETTING: Endocrinology and reproductive medicine teaching hospital departments. PATIENTS: Familial POI cases were recruited as part of a nationwide multicentric cohort. A total of 36 index cases in 36 different families were studied. Fifty-two relatives were available, including 25 with POI and 27 affected who were nonaffected. Karyotype analysis, FMR1 screening, single nucleotide polymorphism array analysis, and WES were performed in all subjects. INTERVENTIONS: None. MAIN OUTCOME MEASURES: The primary outcome was a molecular etiology, as diagnosed by karyotype, FMR1 screening, single nucleotide polymorphism array, and WES. RESULTS: A likely molecular etiology (pathogenic or likely pathogenic variant) was identified in 18 of 36 index cases (50% diagnostic yield). In 12 families, we found a pathogenic or likely pathogenic variant in a gene previously incriminated in POI, and in 6 families, we found a pathogenic or likely pathogenic variant in new candidate genes. Most of the variants identified were located in genes involved in cell division and meiosis (n = 11) or DNA repair (n = 4). CONCLUSIONS: The genetic etiologic diagnosis in POI allows for genetic familial counseling, anticipated pregnancy planning, and ovarian tissue preservation or oocyte preservation. Identifying new genes may lead to future development of therapeutics in reproduction based on disrupted molecular pathways. CLINICAL TRIAL REGISTRATION NUMBER: NCT 01177891.
引用
- Rouen A, Rogers E, Kerlan V, et al. Whole exome sequencing in a cohort of familial premature ovarian insufficiency cases reveals a broad array of pathogenic or likely pathogenic variants in 50% of families. Fertil Steril. 2022. PMID: 35115167. doi:10.1016/j.fertnstert.2021.12.023
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。